Stocks and Investing
Stocks and Investing
Fri, August 9, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Michael Ulz Upgraded (THRD) to Buy and Increased Target to $20 on, Aug 9th, 2024
Michael Ulz of Morgan Stanley, Upgraded "Third Harmonic Bio, Inc." (THRD) to Buy and Increased Target from $12 to $20 on, Aug 9th, 2024.
Michael has made no other calls on THRD in the last 4 months.
There are 2 other peers that have a rating on THRD. Out of the 2 peers that are also analyzing THRD, 0 agree with Michael's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Michael
- Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $23 on, Tuesday, June 18th, 2024
- Laura Prendergast of "Raymond James" Initiated at Buy and Held Target at $18 on, Friday, June 7th, 2024
Contributing Sources